RVPH Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings Inc is a clinical development pharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic and inflammatory diseases.

As of 09/16/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/18/2018
Outstanding shares:  13,388,986
Average volume:  228,348
Market cap:   $55,430,402
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    76152G100
ISIN:        US76152G1004
Sedol:      BL96WV0
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.61
PS ratio:   0.00
Return on equity:   -5.69%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy